Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03999086 · ClinicalTrials.gov registry record

Thromboelastography-Guided Fluid Management in Spinal Surgery

A clinical trial of Spinal Fusion, sponsored by Mayo Clinic.

Completed
Registry status
50
Enrollment target
1
Study location

NCT03999086: Completed study of Spinal Fusion, sponsored by Mayo Clinic.

NCT03999086 is a study of Spinal Fusion that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 481-participant average among 19 other Spinal Fusion trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03999086, a study of Spinal Fusion, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.

Primary Outcome

Amount of blood loss measured in units of cc(mL)

Conditions Studied

Interventions

  • OTHER Control Group
  • PROCEDURE Intervention

Study Locations (1)

Arizona

  • Mayo Clinic - Scottsdale

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-01-12
Est. Completion 2019-11-08
Mayo Clinic

2,844 total trials

What the finished NCT03999086 record still lists

NCT03999086 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 481-participant average among 19 other Spinal Fusion trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.

NCT03999086 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT03999086 about?

NCT03999086 is a clinical study titled "Thromboelastography-Guided Fluid Management in Spinal Surgery". The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.

What is the current status of trial NCT03999086?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2018-01-12. Estimated completion is 2019-11-08.

What conditions does trial NCT03999086 study?

This clinical trial studies the following conditions: Spinal Fusion.

What interventions are being tested in trial NCT03999086?

The interventions under investigation include: Control Group (OTHER), Intervention (PROCEDURE).

Who is sponsoring clinical trial NCT03999086?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03999086 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Fusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03999086's enrollment target sits among peer trials

50 14th of 19 higher than 3 of 19 other Spinal Fusion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03999086, the US trial registry maintained by the National Library of Medicine. NCT03999086 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.